Shanghai Kaibao Pharmaceutical Co Ltd

SZSE:300039

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shanghai Kaibao Pharmaceutical Co Ltd's stock price target?

Price Target

7 CNY

According to Wall Street analysts, the average 1-year price target for Shanghai Kaibao Pharmaceutical Co Ltd is 7 CNY .

What is Shanghai Kaibao Pharmaceutical Co Ltd's Revenue forecast?

Projected CAGR

5%

For the last 8 years the compound annual growth rate for Shanghai Kaibao Pharmaceutical Co Ltd's revenue is -5%. The projected CAGR for the next 6 years is 5%.

What is Shanghai Kaibao Pharmaceutical Co Ltd's Operating Income forecast?

Projected CAGR

11%

For the last 8 years the compound annual growth rate for Shanghai Kaibao Pharmaceutical Co Ltd's operating income is -8%. The projected CAGR for the next 7 years is 11%.

What is Shanghai Kaibao Pharmaceutical Co Ltd's Net Income forecast?

Projected CAGR

6%

For the last 8 years the compound annual growth rate for Shanghai Kaibao Pharmaceutical Co Ltd's net income is -7%. The projected CAGR for the next 6 years is 6%.